Socio-professional Profile of Individuals Living with Human Immunodeficiency Virus Who Tested Positive for HBsAg At the Laboratory of the Regional Hospital of Faranah, Guinea, 2022

Aïssatou Boiro^1, , Ousmane Camara², Ibrahima Sory Sow¹, Mariama Diallo¹, Thierno Amadou Labé Baldé¹, Mamadou Ciré Diallo¹, Mamadou Boundoukhoura Bah¹, Sanaba Boumbaly³ and Mohamed Sahar Traoré¹

¹Microbiologie, Guinea Institute for Applied Biology Research (IRBAG), Kindia, Republic of Guinea

²Loboratory, Faranah Regional Hospital, Faranah, Guinea

³Loboratory, Virology Research Centre, Conakry, Guinea

Cite this paper:
Aïssatou Boiro, Ousmane Camara, Ibrahima Sory Sow, Mariama Diallo, Thierno Amadou Labé Baldé, Mamadou Ciré Diallo, Mamadou Boundoukhoura Bah, Sanaba Boumbaly and Mohamed Sahar Traoré. Socio-professional Profile of Individuals Living with Human Immunodeficiency Virus Who Tested Positive for HBsAg At the Laboratory of the Regional Hospital of Faranah, Guinea, 2022. Journal of Applied & Environmental Microbiology. 2026; 14(1):9-13. doi: 10.12691/jaem-14-1-2

Abstract

Co-infection with Human Immunodeficiency Virus (HIV) and Hepatitis B Surface Antigen (HBsAg) is a major public health challenge, particularly in sub-Saharan Africa. Knowledge of the socio-professional profiles of the individuals concerned is essential to strengthen appropriate prevention and treatment strategies. This study aimed to estimate the frequency of hepatitis B among people living with HIV at the Faranah Regional Hospital in 2022 and to identify the socio-professional factors associated with this co-infection. A cross-sectional study was conducted among 158 people living with HIV who were seen at the laboratory of the Faranah Regional Hospital between October and December 2022. We used the ‘SD-Bio line AgHBs’ immunochromatographic test for analysis. The data showed a seroprevalence of 18.82% for HIV/HBV co-infection, with a 95% confidence interval (CI): 12.82% - 25.02%. The median age was 32 years with an interquartile range of 17 years. Among the study population, women were the most co-infected (21.4%); the age group (adolescents, young people and adults) was the most affected with a rate of 93.3%; unmarried people predominated over married people with 60%; artisans and traders represented 63.3%. This study has enabled us to highlight the high prevalence of HIV/HBV co-infection and to understand the profiles of people living with HIV in Faranah. It would be crucial to implement effective diagnostic strategies in order to improve the quality of life of PLHIV in the Republic of Guinea.

Keywords:
PLHIV HBsAg Socio-professional characteristics Faranah Guinea

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	OMS 2024, Hépatite B https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b. Consulté le 15.10.2024.
[2]	Avila-Rios S, García-Morales C, Reyes-Terán G, González-Rodríguez A, Matías-Florentino M, Mehta SR, Chaillon A.2022.Phylodynamics of HIV in the Mexico City Metropolitan Region. J Virol96:e00708-22.
[3]	Anteneh, Zelalem Alamrew, Estifanose Wondaye, and Endalkachew Worku Mengesha, ‘Hepatitis B Virus Infection and Its Determinants among HIV Positive Pregnant Women: Multicenter Unmatched Case-Control Study’, PloS One, 16.4 (2021), p. e0251084.
[4]	Mossoro-Kpinde, C.D., Gbangba-Ngai, E., Mossoro-Kpinde, H.D., Camengo, Police, S.M., Kobangue, L., Selehina, E., Mbale, M. and Baïpo, F. (2016) Dépistage de l’antigene HBs chez les malades du VIH à Bangui. RevueBio-Africa, 15, 39-43.
[5]	WHO (2016) Global Health Sector Strategy on Viral Hepatitis. WHO, Geneva. https:// www.who.int/ news-room/ fact-sheets/detail/hepatitis-b.
[6]	Bonacci, M., Louie, S., Bzowej, N. and Wohl, A.R. (2004) Survival in Patients with HIV Infection and Viral Hepatitis B or C: A Cohort Study. AIDS, 18, Article ID: 203945.
[7]	Alessandro R. Zanetti, Pierre Van Damme, and Daniel Shouval, ‘The Global Impact of Vaccination against Hepatitis B: A Historical Overview’, Vaccine, 26.49 (2008), pp. 6266–73.
[8]	Keita, M, Fadiga AG, Soumah MM, Sylla D, Traore FA, Biané B, and others, ‘Co-Infection VIH et Virus de l’hépatite B Au Service d’hématologie de l’hôpital National Ignace Deen (Guinée-Conakry)’, Annales de Dermatologie et de Vénéréologie, 141.12 (2014), p. S442.
[9]	Steve Leumi, Jean Joel Bigna, Marie A Amougou, Anderson Ngouo, Ulrich Flore Nyaga, Jean Jacques Noubiap, Global Burden of Hepatitis B Infection in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, Volume 71, Issue 11, 1 December 2020, Pages 2799–2806.
[10]	Tékpa, G., Mossoro-Kpinde, H.D., Nazilari, J.G., Komoyo, G. and Diémer, S.C.H. (2024) Socio-Demographic and Occupational Aspects of HIVHBV Co-Infection in Bangui, Central African Republic (CAR): Hospital-Based Cross-Sectional Study. Advances in Infectious Diseases, 14, 310-321.
[11]	Adrià Ramírez Mena, Ndeye Fatou Ngom, Judicaël Tine, Kine Ndiaye, Louise Fortes, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Daye Ka, Moussa Seydi, Gilles Wandeler, Prévalence et prédicteurs de la fibrose hépatique chez les personnes vivant avec l'hépatite B au Sénégal, Virus.
[12]	M.S. Ouedraogo, S. Bara/Tiendrebeogo, P.G. Tapsoba, N. Korsaga/Some, A.N. Ouedraogo, L. Tiendrebeogo, A. Yameogo, F. Barro/Traoré, P. Niamba, A. Traoré. Coïnfection VIH/ Hépatite B et C chez les personnes vivant avec le VIH dans une structure associative de prise en charge médicale de la ville de Ouagadougou (BURKINA FASO) Annales de Dermatologie et de Vénéréologie, Volume 143, Numéro 4, Supplément 1, avril 2016, page S25.
[13]	Makanera, Abdoulaye, Ignace Dramou, Sidikiba Sidibe, Mariam Conde, Ousmane Sy, Lansana Bomba Camara, and others, ‘Séroprévalence de La Co-Infection VIH /Virus de l’hépatite B à l’Hôpital de l’Amitié Sino-Guinéenne (HASIGUI) Kipé/Conakry (Guinée)’, Journal of Applied Biosciences, 135 (2019), pp. 13798–807.
[14]	Camara, A., Thea, E., Haba, I., Youla, Y., Diallo, I., Diallo, M., Kaba, D., Camara, J., Condé, M., Soropogui, B., Kourouma, K., Tounkara, T., Mbengue, B., Touré, A. et Boumbaly, S. (2024) Séroprévalence du virus de l’immunodéficience humaine et de l’hépatite B chez les donneurs de sang au Centre régional de transfusion sanguine de N’Zérékoré en Guinée. Journal ouvert d’immunologie, 14, 33-45.
[15]	Annuaire_INS_2019_opt. Pdf https:// www.statguinee.org/ images/ Documents/ Publications/ INS/ annuelles/ annuaire/ Annuaire_ INS_2019_opt.pdf.
[16]	Kaba, D., Diallo, M. S., Barry, R., Diakite, M., Diane, B. F., Keita, F., … Cisse, M. (2020). Prévalence de l’Antigène HBS chez les Personnes Infectées par le VIH à l’Hôpital de Jour de Donka (Guinée). HEALTH SCIENCES AND DISEASE, 21(2).
[17]	Comlan Albert Dovonou and others, ‘[Prevalence of hepatitis B in people infected with HIV in Parakou in Benin]’, The Pan African Medical Journal, 20 (2015), p. 125.
[18]	Isa I, Aminu M, Abdullahi SA, Sani MA, Usman MA, Esona MD, Ella EE. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Infection among Students in Ahmadu Bello University, Zaria, Nigeria. Arch Med Biomed Res. 2017; 3(2): 77-90.